Celecoxib is as efficacious as naproxen in the management of acute shoulder pain

Journal of International Medical Research

Volumn 31, Issue 2, 2003, Pages 102-112

  Bertin, P ^a   Behier J M ^d   Noel E ^b   Leroux, J L ^c  

^a DUPUYTREN UNIVERSITY HOSPITAL   (France)

^b EDOUARD HERRIOT HOSPITAL   (France)

^c DEPARTMENT OF NEUROLOGY   (France)

^d NONE

Author keywords

Acute pain; Analgesia; Celecoxib; Cyclo oxygenase (COX) 2 specific inhibitors; Naproxen; Shoulder pain; Visual analogue scale (VAS)

Indexed keywords

ANALGESIC AGENT; CELECOXIB; CYCLOOXYGENASE 2 INHIBITOR; NAPROXEN; NONSTEROID ANTIINFLAMMATORY AGENT;

ADULT; AGED; CLINICAL TRIAL; COLON DISEASE; COLON DIVERTICULOSIS; CONFIDENCE INTERVAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIGESTIVE SYSTEM FUNCTION DISORDER; DISEASE SEVERITY; DOSE RESPONSE; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG SAFETY; EPIGASTRIC PAIN; FEMALE; FUNCTIONAL ASSESSMENT; HUMAN; INCIDENCE; MALE; PAIN ASSESSMENT; RANDOMIZED CONTROLLED TRIAL; REST; REVIEW; SHOULDER PAIN; STATISTICAL SIGNIFICANCE; STOMACH ULCER; TREATMENT WITHDRAWAL; VISUAL ANALOG SCALE;

EID: 0037691653     PISSN: 03000605     EISSN: None     Source Type: Journal    
DOI: 10.1177/147323000303100206     Document Type: Review

References (43)

1. Yamamoto M, Sugano T, Kashiwazaki S, Kageyama T, Mizushima Y, Kameyama M: Double-blind comparison of piroxicam and indomethacin in the treatment of cervicobrachial syndrome and periarthritis scapulohumeralis (stiff shoulder). Eur J Rheumatol Inflamm 1983; 6: 266-273.
2. Lacey PH, Dodd GD, Shannon DJ: A double blind, placebo controlled study of piroxicam in the management of acute musculoskeletal disorders. Eur J Rheumatol Inflamm 1984; 7: 95-104.
3. Smith MD, Thomas D, McCredie M, Brooks PM: Piroxicam versus naproxen in the treatment of painful shoulder. Pharmatherapeutica 1986; 4: 585-589.
4. Heere LP: Piroxicam in acute musculoskeletal disorders and sports injuries. Am J Med 1988; 84: 50-55.
5. McIlwain HH, Platt RD: Piroxicam versus naproxen in the treatment of acute musculoskeletal disorders in athletes. Am J Med 1988; 84: 56-60.
6. Vidal L, Kneer W, Baturone M, Sigmund R: Meloxicam in acute episodes of soft-tissue rheumatism of the shoulder. Inflamm Res 2001; 50 (Suppl 1): S24-S29.
7. Fries JF: NSAID gastropathy: epidemiology. J Musculoskel Med 1991; 8: 21-28.
8. Roth SH: NSAID gastropathy. Arch Intern Med 1996; 156: 1623-1628.
9. Gabriel SE, Jaakkimainen L, Bombardier C: Risk for serious gastrointestinal complications related to use of nonsteroidal antiinflammatory drugs. A meta-analysis. Ann Intern Med 1991; 115: 787-796.
10. Masferrer JL, Zweifel BS, Manning PT, Hauser SD, Leahy KM, Smith WG, et al: Selective inhibition of inducible cyclooxygenase 2 in vivo is anti-inflammatory and nonulcerogenic. Proc Natl Acad Sci U S A 1994; 91: 3228-3232.
11. Vane J: Towards a better aspirin. Nature 1994; 367: 215-216.
12. Anderson GD, Hauser SD, McGarity KL, Bremer ME, Isakson PC, Gregory SA: Selective inhibition of cyclooxygenase (COX)-2 reverses inflammation and expression of COX-2 and interleukin 6 in rat adjuvant arthritis. J Clin Invest 1996; 97: 2672-2679.
13. Gierse JK, Hauser SD, Creely DP, Koboldt C, Rangwala SH, Isaksc PC, et al: Expression and selective inhibition of the constitutive and inducible forms of human cyclo-oxygenase. Biochem J 1995; 305: 479-484.
14. Gierse JK, McDonald JJ, Hauser SD, Rangwala SH, Koboldt CM, Siebert K: A single amino acid difference between cyclooxygenase-1 (COX-1) and -2 (COX-2) reverses the selectivity of COX-2 specific inhibitors. J Biol Chem 1996; 271: 15810-15814.
15. Bensen WG, Zhao SZ, Burke TA, Zabinski RA, Makuch RW, Maurath CJ, et al: Upper gastrointestinal tolerability of celecoxib, a COX-2 specific inhibitor, compared to naproxen and placebo, J Rheumatol 2000; 27: 1876-1883.
16. Goldstein JL, Silverstein FE, Agrawal NM, Hubbard RC, Kaiser J, Maurath CJ, et al: Reduced risk of upper gastrointestinal ulcer complications with celecoxib, a novel COX-2 inhibitor. Am J Gastroenterol 2000; 95: 1681-1690.
17. Leese PT, Hubbard RC, Karim A, Isakson PC, Yu SS, Geis GS: Effects of celecoxib, a novel cyclooxygenase-2 inhibitor, on platelet function in healthy adults: a randomized, controlled trial. J Clin Pharmacol 2000; 40: 124-132.
18. Silverstein FE, Faich G, Goldstein JL, Simon LS, Pincus T, Whelton A, et al: Gastrointestinal toxicity with celecoxib vs nonsteroidal antiinflammatory drugs for osteoarthritis and rheumatoid arthritis. JAMA 2000; 284: 1247-1255.
19. Emery P, Zeidler H, Kvien TK, Guslandi M, Naudin R, Stead H, et al: Celecoxib versus diclofenac in long-term management of rheumatoid arthritis: randomised double-blind comparison. Lancet 1999; 354: 2106-2111.
20. Clemett D, Goa KL: Celecoxib: a review of its use in osteoarthritis, rheumatoid arthritis and acute pain. Drugs 2000; 59: 957-980.
21. McKenna F, Borenstein D, Wendt H, Wallemark C, Lefkowith JB, Geis GS: Celecoxib versus diclofenac in the management of osteoarthritis of the knee. Scand J Rheumatol 2001; 30: 11-18.
22. Camu F, Beecher T, Recker DP, Verburg KM: Valdecoxib, a COX-2-specific inhibitor, is an efficacious, opioid-sparing analgesic in patients undergoing hip arthroplasty. Am J Ther 2002; 9: 43-51.
23. Daniels SE, Grossman EH, Kuss ME, Talwalker S, Hubbard RC: A double-blind, randomized comparison of intramuscularly and intravenously administered parecoxib sodium versus ketorolac and placebo in a post-oral surgery pain model. Clin Ther 2001; 23: 1018-1031.
24. Daniels SE, Desjardins PJ, Talwalker S, Recker DP, Verburg KM: The analgesic efficacy of valdecoxib vs oxycodone/acetaminophen after oral surgery. J Am Dent Assoc 2002; 133: 611-621.
25. Fricke J, Varkalis J, Zwillich S, Adler R, Forester E, Recker DP, et al: Valdecoxib is more efficacious than rofecoxib in relieving pain associated with oral surgery. Am J Ther 2002; 9: 89-97.
26. Hubbard RC, Mehlisch DR, Jasper DR, Nugent MJ, Yu S, Isakson PC: SC-58635, a highly selective inhibitor of COX-2, is an effective analgesic in an acute post-surgical pain model (abstract). J Invest Med 1996; 44: 293.
27. Malmstrom K, Daniels S, Kotey P, Seidenberg BC, Desjardins PJ: Comparison of rofecoxib and celecoxib, two cyclooxygenase-2 inhibitors, in postoperative dental pain: a randomized, placebo- and active-comparator-controlled clinical trial. Clin Ther 1999; 21: 1653-1663.
28. Ekman EF, Fiechtner JJ, Levy S, Fort JG: Efficacy of celecoxib versus ibuprofen in the treatment of acute pain: a multicenter, double-blind, randomized controlled trial in acute ankle sprain. Am J Orthop 2002; 31: 445-451.
29. Gimbel JS, Brugger A, Zhao W, Verburg KM, Geis GS: Efficacy and tolerability of celecoxib versus hydrocodone/acetaminophen in the treatment of pain after ambulatory orthopedic surgery in adults. Clin Ther 2001; 23: 228-241.
30. Petrella R, Ekman E, Levy S, Fort J: Comparison between celecoxib and naproxen in the treatment of ankle sprain (poster). Presented at the 106th AOA-American Osteopathic Association, October 2001, San Diego, CA, USA.
31. Yepes JP, Ekman E, Levy SD, Fort JG: Efficacy of celecoxib vs diclofenac in the treatment of acute pain: a multicenter, double-blind, randomized control trial in acute ankle sprain (poster). Presented at the European Congress of Rheumatology, Stockholm, Sweden, 12-15 June, 2002.
32. Thomas T: Evaluation fonctionnelle en matière de pathologie de la coiffe des rotateurs. Rev Rhum Suppl Pédag 1996; 63 (1 Suppl): 56SP-68SP.
33. Machin D, Campbell MJ, Fayers PM, Pinol APY: Comparing independent groups for binary, ordered categorical and continuous data. In: Sample Size Tables for Clinical Studies (2nd edn). Blackwell Science, 1997; pp18-68.
34. Todd PA, Beresford R: Pirprofen: a review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy. Drugs 1986; 32: 509-537.
35. Carr AJ: Shoulder. In: Orthopaedics in Primary Care (Carr AJ, Harnden A, eds). Oxford: Butterworth-Heinemann, 1997; pp1-18.
36. van der Windt DA, van der Heijden GJ, van den Berg SG, ter Reit G, de Winter AF, Bouter LM: Ultrasound therapy for musculoskeletal disorders: a systematic review. Pain 1999; 81: 257-271.
37. van der Windt DA, Van Der Heijden GJ, Van Den Berg SC, Ter Reit G, De Winter AF, Bouter LM: Ultrasound therapy for acute ankle sprains (Cochrane Review). Cochrane Database Syst Rev 2002; 1: CD001250.
38. Wright A, Sluka KA: Nonpharmacological treatments for musculoskeletal pain. Clin J Pain 2001; 17: 33-46.
39. Ginn KA, Herbert RD, Khouw W, Lee R: A randomized, controlled clinical trial of a treatment for shoulder pain. Phys Ther 1997; 77: 802-809, 810-811.
40. Winters JC, Sobel JS, Groenier KH, Arendzen HJ, Meyboom-de Jong B: Comparison of physiotherapy, manipulation, and corticosteroid injection for treating shoulder complaints in general practice: randomised, single blind study. BMJ 1997; 314: 1320-1325.
41. Johansson K, Adolfsson L, Foldevi M: Attitudes toward management of patients with subacromial pain in Swedish primary care. Fam Pract 1999; 16: 233-237.
42. Lecomte J, Buyse H, Taymans J, Monti T: Treatment of tendinitis and bursitis: a comparison of nimesulide and naproxen sodium in a double-blind parallel trial. Eur J Rheumatol Inflamm 1994; 14: 29-32.
43. Dougados M, Behier JM, Jolchine I, Calin A, van der Heijde D, Olivieri I, et al: Efficacy of celecoxib, a cyclooxygenase 2-specific inhibitor, in the treatment of ankylosing spondylitis: a six-week controlled study with comparison against placebo and against a conventional nonsteroidal antiinflammatory drug. Arthritis Rheum 2001; 44: 180-185.